TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OCS
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
37.6% 82.7% 63.8% 88.3% 87.2% 92.8%
30.2% 79.7% 53.4% 33.5% 23.0% 34.5%
30.2% 79.7% 53.4% 80.1% 82.0% 90.3%
7.0% 1.6% 2.9% 7.0% 0.6% 0.4%
0.4% -1.6% -2.9% -1.1% – –
– – 3.0% – – –
53.3% 15.0% 32.9% 10.7% 11.0% 5.6%
366.5% 205.0% 364.4% 18.0% 39.0% 16.9%
26.5% 7.0% 32.4% 16.7% 36.8% 15.6%
1.1% 0.3% 0.4% 0.2% 0.3% 0.2%
4.8% 1.4% 10.4% 6.6% 4.9% 0.8%
329.5% 195.5% 330.4% – – –
-266.5% -105.0% -264.4% 82.0% 61.0% 83.1%
-327.9% -124.5% -299.5% -174.7% -237.3% -163.0%
199.8% 56.4% 88.3% 26.1% 33.6% 22.2%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?